Clinical trial NCT00505830: Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome: AQ, EQ and SQ
Official title: Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome : Autism Spectrum Quotient (AQ) Empathy Quotient (EQ) and Systemizing Quotient (SQ)
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Asperger Syndrome
Autism
Keywords: Asperger Syndrom
Autism Quotient
French version
screening
diagnostic test
accuracy
Lead sponsor: Groupe Francais d'Epidemiologie Psychiatrique
Sponsor class: OTHER
Collaborators: name: Joint Clinical Research Center
First posted: 2007-07-25
Enrollment: 450
Sex: ALL
Minimum age (years): 12
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Observational model: DEFINED_POPULATION
Time perspective: PROSPECTIVE

Brief summary: Autism is considered as an invading disorder of the development. Asperger Syndrome (AS) is a particular form of autism and is difficult to diagnose. The Autism Spectrum Quotient (AQ) has been developed in order to measure the degree of autistic traits in autistic adolescent with normal intelligence (Baron-Cohen et al. 2001, 2006). AQ comprises 50 questions, with 5 groups of 10 questions assessing imagination, social skills, attention switching, attention to detail and communication skills. Each of these items scores 1 point if the respondent records abnormal or autistic like behaviour. The minimum score on the AQ is 0 and the maximum 50.

The principal objective of this study is to evaluate the accuracy of the French version of Autism Spectrum Quotient questionnaire.

Secondary objectives are to:

Evaluate if EQ and SQ can distinguish adolescents without psychiatric syndromes from those with classical autism or AS.

Evaluate if AQ, EQ and SQ can distinguish adolescents with psychiatric disorders from autistic adolescents.

Define the threshold of positivity for the 3 questionnaires.

Detailed description: 4 groups of participants will be screened with the questionnaires: Group 1: 50 adolescents with AS or high functioning autism (HFS) diagnosed by psychiatrists using established criteria and with an IQ \>85.

Group 2: 50 adolescents with AS or classical autism diagnosed by psychiatrists using established criteria 70\<IQ\<84.

Group 3: 50 adolescents with psychiatric disorders. Group 4: Sample of 50 healthy adolescents selected randomly from 200. The questionnaires are given to the parents of adolescents during the first meeting. Parents are invited to send them back to the clinical investigation centre of Lyon (France).

Multicentre study: 8 clinical centres and 18 paediatricians

Eligibility criteria: Inclusion Criteria:

Group 1 (AS/HFA) and 2 (AS/classic autism) :

* Boys and girls aged 12 to 18
* Patients with autism or Asperger syndrome according to the diagnostic criteria (ICD 10)
* Patients receiving education in an ordinary school
* IQ\>70

Group 3 (adolescents with psychiatric disorders):

* Boys and girls aged 12 to 18
* Patients hospitalized on a psychiatric ward or at a psychiatrics patient visit or psychiatric consultation wit hout autistic syndrome
* Patients receiving education in an ordinary school when not in hospital

Group 4 (adolescent without psychiatric syndrome):

* Boys and girls aged 12 to 18
* Patients receiving education in an ordinary school

Exclusion Criteria:

For all groups :

* Problem with language or comprehension
* Participants who have not given their consent

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
city: Lyon
country: France
facility: Centre Hospitalier Saint Jean de Dieu
Study officials:
affiliation: Centre Hospitalier Saint Jean de Dieu
name: Sabine Manificat, MDH
role: PRINCIPAL_INVESTIGATOR
References: